Who
Josh Mandel-Brehm
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, CAMP4 Therapeutics; Director, ProMIS Neurosciences.
In numbers
- Trades disclosed
- 15
- Buys
- 2
- Sells
- 0
- Bought
- $32K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 3 Oct 2024
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,551 at $1.65 | filing |
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,551 at $1.65 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —580,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —580,000 at $0.00 | filing |
| 11 Dec 2025filed 22 Dec 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —425,000 at $0.00 | filing |
| 11 Sep 2025filed 11 Sep 2025 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $9,9996,060 at $1.65 | filing |
| 12 Jun 2025filed 16 Jun 2025 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 15 Oct 2024filed 15 Oct 2024 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —6,791 | filing |
| 15 Oct 2024filed 15 Oct 2024 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Code C | —605 | filing |
| 3 Oct 2024filed 7 Oct 2024 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.